4-Amino-7-chloroquinoline - CAS 1198-40-9
Catalog: |
BB004666 |
Product Name: |
4-Amino-7-chloroquinoline |
CAS: |
1198-40-9 |
Synonyms: |
7-chloroquinolin-4-amine |
IUPAC Name: | 7-chloroquinolin-4-amine |
Description: | 4-Amino-7-chloroquinoline (CAS# 1198-40-9) is an aminoquinoline that complexes ferriprotoporphyrin IX (Fe(III)PPIX) and inhibits its conversion to β-hematin (hemozoin). |
Molecular Weight: | 178.62 |
Molecular Formula: | C9H7ClN2 |
Canonical SMILES: | C1=CC2=C(C=CN=C2C=C1Cl)N |
InChI: | InChI=1S/C9H7ClN2/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5H,(H2,11,12) |
InChI Key: | NDRZSRWMMUGOBP-UHFFFAOYSA-N |
Boiling Point: | 366.8 °C at 760 mmHg |
Purity: | 95 % |
Density: | 1.363 g/cm3 |
Storage: | Keep in dark place, Inert atmosphere, 2-8 °C |
MDL: | MFCD00828822 |
LogP: | 3.05160 |
GHS Hazard Statement: | H301 (97.5%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P310, P305+P351+P338, P321, P330, P337+P313, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112225697-A | Preparation method of enantiomer pure chloroquine and chloroquine phosphate | 20201016 |
CN-112266356-A | Asymmetric synthesis method of (S) -chloroquine phosphate | 20200925 |
CN-111635358-A | Preparation method of hydroxychloroquine | 20200629 |
WO-2021204717-A1 | Aminoquinolines for treating coronavirus infections | 20200406 |
WO-2021202669-A2 | Nucleoside and nucleotide conjugate compounds and uses thereof | 20200401 |
PMID | Publication Date | Title | Journal |
24742203 | 20140522 | Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria | Journal of medicinal chemistry |
24012713 | 20131101 | Synthesis, characterization, antiparasitic and cytotoxic evaluation of thioureas conjugated to polyamine scaffolds | European journal of medicinal chemistry |
23331618 | 20130501 | 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum | Chemical biology & drug design |
22901673 | 20121001 | Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline | Bioorganic & medicinal chemistry |
22917857 | 20121001 | Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline | Bioorganic & medicinal chemistry |
Complexity: | 163 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 178.0297759 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 178.0297759 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 38.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[57166-92-4]
Methylenediamine dihydrochloride
-
[1808-26-0]
Ethyl arachidonate
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[6315-52-2]
Ethylene di(p-toluenesulfonate)
-
[10128-55-9]
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-2-naphthalenesulfonamide
INDUSTRY LEADERS TRUST OUR PRODUCTS